United States · FDA National Drug Code directory

GABAPENTIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72865-254_702f8307-681f-440d-9f1d-3d26141a914b
Product NDC
72865-254
Form
CAPSULE
Composition / generic term
gabapentin
Labeler
XLCare Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20210510
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 400 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 500 CAPSULE in 1 BOTTLE (72865-254-05) · 72865-254-05
  • 270 CAPSULE in 1 BOTTLE (72865-254-27) · 72865-254-27
  • 90 CAPSULE in 1 BOTTLE (72865-254-90) · 72865-254-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
GABAPENTIN — United States | Molindra Medicines